Antioxidants enhance the recovery of three cycles of bleomycin etoposide and cisplatin induced testicular dysfunction pituitary testicular axis and fertility in rats

Antioxidants enhance recovery of testicular effects of therapeutically relevant dose levels of bleomycin, etoposide, and cisplatin. The antioxidants up-regulate germ cell renewal and recovery of Sertoli cell functions, fertility, and the pituitary-testis axis.

Like Comment

Authors

Narayana Kilarkaje, Alyaa M. Mousa, Ph.D., Maie M. Al-Bader, Ph.D., Khalid M. Khan, Ph.D.

Volume 100, Issue 4, Pages 1151-1159.e5, October 2013

Abstract

Objective:

To investigate the effects of an antioxidant cocktail (AC) on bleomycin, etoposide, and cisplatin (BEP)–induced testicular dysfunction.

Design:

In vivo study.

Setting:

Research laboratory.

Animal(s):

Adult male and female Sprague-Dawley rats.

Intervention(s):

The rats were treated with three cycles of 21 days each of therapeutically relevant dose levels of BEP (0.75, 7.5, and 1.5 mg/kg) with or without the AC (a mixture of α-tocopherol, L-ascorbic acid, Zn, and Se).

Main Outcome Measure(s):

Sperm parameters, fertility, serum hormone levels (ELISA), testicular histopathology, and expression of proliferating cell nuclear antigen (PCNA), and transferrin (Western blotting and immunohistochemistry) were evaluated at the end of treatment and a 63-day recovery period.

Result(s):

At the end of treatment, the AC improved BEP-induced decrease in sperm motility and increase in abnormality but had no effect on reduced sperm count, fertility, and tubular atrophy, although it up-regulated germ cell proliferation. The AC normalized reduced inhibin B levels, but had no effect on decreased transferrin and testosterone and elevated LH levels. At the end of the recovery period, the AC enhanced the expression of PCNA and transferrin, repopulation of germ cells, LH-testosterone axis, and fertility, but had no effect on reduced FSH and elevated inhibin B levels.

Conclusion(s):

The antioxidants protect and then enhance the recovery of testicular and reproductive endocrine functions when administered concomitantly with BEP therapy. The AC may be beneficial to regain testicular functions after chemotherapy.

Read the full text at: http://www.fertstert.org/article/S0015-0282(13)00713-9/fulltext


Go to the profile of Fertility and Sterility

Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. The journal publishes juried original scientific articles in clinical and laboratory research relevant to reproductive endocrinology, urology, andrology, physiology, immunology, genetics, contraception, and menopause. Fertility and Sterility® encourages and supports meaningful basic and clinical research, and facilitates and promotes excellence in professional education, in the field of reproductive medicine.

No comments yet.